Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05226884 · ClinicalTrials.gov registry record
Intermediate Vision in Patients With Clareon IOLs Compared to Eyhance IOLs
A clinical trial, sponsored by Berkeley Eye Center.
- Completed
- Registry status
- 310
- Enrollment target
NCT05226884: Completed study, sponsored by Berkeley Eye Center.
NCT05226884 is a clinical trial that has completed, run by Berkeley Eye Center. The registered enrollment target is 310 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05226884 has completed, sponsored by Berkeley Eye Center.
- COMPLETED
- Registry status
- 310 participants
- Enrollment target
Study Summary
Compare visual outcomes in patients with bilateral Clareon Monofocal IOLs versus bilateral Eyhance IOLs.
Primary Outcome
Target-corrected binocular intermediate (66 cm) visual acuity of Clareon monofocal subjects at -0.25 sphere versus Eyhance subjects at plano sphere.
Interventions
- DIAGNOSTIC_TEST Visual Acuity
- DIAGNOSTIC_TEST Defocus Curve
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 310 participants |
| Start Date | 2021-11-30 |
| Est. Completion | 2022-08-06 |
What the finished NCT05226884 record still lists
NCT05226884 is an observational study that tracks outcomes without assigning an intervention. The registered 310 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Visual Acuity is the first listed.
NCT05226884 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05226884 about?
NCT05226884 is a clinical study titled "Intermediate Vision in Patients With Clareon IOLs Compared to Eyhance IOLs". Compare visual outcomes in patients with bilateral Clareon Monofocal IOLs versus bilateral Eyhance IOLs.
What is the current status of trial NCT05226884?
This trial is currently completed. The enrollment target is 310 participants. The study started on 2021-11-30. Estimated completion is 2022-08-06.
What interventions are being tested in trial NCT05226884?
The interventions under investigation include: Visual Acuity (DIAGNOSTIC_TEST), Defocus Curve (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05226884?
This trial is sponsored by Berkeley Eye Center, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03039439 · 310 participants
Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors
- NCT04178018 · 310 participants · NA
Transvaginal Ultrasound and Photoacoustic Imaging of Ovary
- NCT04878094 · 310 participants · Phase 3
A Study of Intra-operative Imaging in Women With Ovarian Cancer
- NCT05459233 · 310 participants · NA
Valve Hemodynamic Optimization Based on Doppler-Echocardiography vs Catheterization Measurements Following ViV TAVR
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI